Biotech

All Articles

8 months after a $213M fundraise, genetics editor Tome produces decreases

.After rearing $213 thousand in 2023-- among the year's biggest private biotech rounds-- Volume Bios...

BioMarin creates exec group with biotech vets-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as ...

Biopharma Q2 VC reached highest degree considering that '22, while M&ampA decreased

.Venture capital funding right into biopharma cheered $9.2 billion around 215 handle the second four...

Bicara, Zenas seek IPOs to press late-phase assets toward market

.Bicara Rehabs and also Zenas Biopharma have given new motivation to the IPO market with filings tha...

Genentech to finalize cancer cells immunology analysis department

.Genentech will definitely shut its cancer cells immunology investigation department, and also devic...

Kezar goes down solid cyst yet to prove its own worth in phase 1 test

.Kezar Life Sciences is actually dropping its dim period 1 solid tumor medication as the biotech goe...

Acelyrin drops izokibep, lays off 3rd of workers

.Despite izokibep sustaining its newfound winning touch in the facility, Acelyrin is no longer focus...

Rivus' phase 2 obesity-related cardiac arrest test hits endpoint

.Rivus Pharmaceuticals has actually plumped up the customers of its fat-busting, muscle-sparing medi...

Ovid standstills preclinical work, IV course after soticlestat neglect

.Ovid Therapeutics already disclosed last month that it was trimming back its own head count as the ...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has opened up a $700 million R&ampD facility in the Boston ma Port, boosting its own RNA ...